Rovco enters US market with strategic appointment
Johnson was head of Oceaneering’s global subsea inspection business unit.
New projects boost revenue at Frontier Developments
The chief executive of Cambridge-based video game publisher Frontier Developments has said he "looks forward with confidence" after achieving record revenue in its 2022 financial year.
Stamp Free appoints new business development director
Digital postage company Stamp Free Limited has appointed Seamus Yendole in the role of business development director as the business progresses toward the commercial launch of its AI phone-based alternative to traditional mailing and returns.
Oxford Space Systems Awarded Significant Contract To Deliver Deployable Offset Reflector Antenna
Oxford Space Systems, a specialist in designing and manufacturing in deployable antennas for Space, has signed a contract with Surrey Satellite Technology to deliver a Synthetic Aperture Radar antenna for the Space Norway MicroSAR satellite system.
Alexa Developer's Venture, Unlikely AI, Raises $20M in Seed Round
Unlikely AI has closed a seed round for $20 million which will go toward developing its approach to artificial intelligence (AI) and adding employees, a press release said Monday (Sept. 12).
Bicycle Therapeutics puts Life Sciences in the vanguard as Business of the Year
Life sciences pioneer Bicycle Therapeutics was last night named as champion company at the Business Weekly Awards at Queens’ College in Cambridge.
One of the last-ever Queen’s Awards is presented to 10to8
10to8 has expressed pride at having received one of the very last Queen’s Awards for Enterprise.
Eagle Genomics Appoints Tarun Rishi as New VP Engineering to Further Scale Platform Capabilities
Eagle Genomics, the platform business pioneering the application of network science to biology across the Food and Nutrition, AgBio, Beauty and Personal Care, and Biopharma industries, has announced the appointment of AI/deep learning leader Tarun Rishi as its new VP Engineering.
Arecor Therapeutics posts solid interim results
Cambridge biopharma company Arecor Therapeutics saw its share price rise more than two per cent after posting a solid set of interim results to June 30 and predicting a transformative next six months for its diabetes franchise.
UK’s FocalPoint raises $17M for its software-based approach to repairing the flaws of GPS
GPS in its many regional flavors has become a ubiquitous feature in phones, smart watches, cars and other connected devices, but for all the location-based features that it helps enable (mapping being the most obvious) it has a lot of shortcomings: it can be slow and inaccurate, it can contribute to faster battery drain and, as people are discovering, it can be manipulated or exploited in unintended and alarming ways.
PhoreMost in drug target discovery collaboration with Roche
PhoreMost will use Siteseeker platform to identify novel targets for Roche’s discovery programmes
Qureight announces world’s first digital biomarker for lung fibrosis will ‘transform’ clinical trials
The AI-based Lung8 imaging software picked up differences in response between patients who had an experimental drug compared with those who took a placebo
Psyomics links up with Hertfordshire Partnership University NHS Foundation Trust
Hertfordshire Trust to invest in mental health care with wide-ranging digital assessment platform.
How Frontier Developments went from roller coasters to F1 Manager 2022
Frontier Developments has a long-established reputation in management games, but not motorsport. Here’s how the team created the superlative F1 Manager 2022.
UK-based Neurofenix raises €7 million for its digital platform that takes a patient-centric approach to rehabilitation
Neurofenix, a healthtech startup with roots in the UK, has picked up a capital investment of €7 million to build out its product line, and kickstart clinical trials in the US.
Cambridge FinTech acquires Japanese global payments business in £3.4m deal
The deal almost doubles the size of Bango and consolidates its position as a leading payments platform for the likes of Netflix and YouTube.
University of Cambridge spin-out Flusso bought for £28m
University of Cambridge spin-out Flusso has been bought for £28m “by a company and a global private equity fund focused on investing in semiconductor companies and other high-tech industries,” it said.
Arecor granted European patents to protect Humira formulations
Patents show potential of innovative Arestat technology and the development of enhanced formulations
Stemnovate set for take-off after being grounded by Covid
It would be considered vulgar in some quarters to call it a rags to riches story, given the quality of the relevant company’s liver-on-chip technology but the financial bounceback of Stemnovate represents a remarkable upturn in fortunes nevertheless.
Dave Excell, Founder of Featurespace – Interview Series
Dave Excell is the Founder of Featurespace, Dave founded Featurespace following his invention of Adaptive Behavioral Analytics, which uses explainable AI to help banks recognize and flag suspicious consumer behavior.